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Abstract
Chondroadherin, a leucine rich repeat extracellular matrix protein with functions in cell to matrix interactions, binds cells via
their a2b1 integrin as well as via cell surface proteoglycans, providing for different sets of signals to the cell. Additionally,
the protein acts as an anchor to the matrix by binding tightly to collagens type I and II as well as type VI. We generated mice
with inactivated chondroadherin gene to provide integrated studies of the role of the protein. The null mice presented
distinct phenotypes with affected cartilage as well as bone. At 3–6 weeks of age the epiphyseal growth plate was widened
most pronounced in the proliferative zone. The proteome of the femoral head articular cartilage at 4 months of age showed
some distinct differences, with increased deposition of cartilage intermediate layer protein 1 and fibronectin in the
chondroadherin deficient mice, more pronounced in the female. Other proteins show decreased levels in the deficient mice,
particularly pronounced for matrilin-1, thrombospondin-1 and notably the members of the a1-antitrypsin family of
proteinase inhibitors as well as for a member of the bone morphogenetic protein growth factor family. Thus, cartilage
homeostasis is distinctly altered. The bone phenotype was expressed in several ways. The number of bone sialoprotein
mRNA expressing cells in the proximal tibial metaphysic was decreased and the osteoid surface was increased possibly
indicating a change in mineral metabolism. Micro-CT revealed lower cortical thickness and increased structure model index,
i.e. the amount of plates and rods composing the bone trabeculas. The structural changes were paralleled by loss of
function, where the null mice showed lower femoral neck failure load and tibial strength during mechanical testing at
4 months of age. The skeletal phenotype points at a role for chondroadherin in both bone and cartilage homeostasis,
however, without leading to altered longitudinal growth.
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Introduction
Bone and cartilage are both made up of relatively few cells
embedded in an abundant extracellular matrix (ECM). In
cartilage, collagen fibrils and the negatively charged proteoglycan
aggrecan, forming large aggregates with hyaluronic acid, consti-
tute the major structural assemblies of the matrix. These two
components provide tissue with tensile strength and resistance
against compressive forces, respectively. The members of the small
leucine rich repeat proteins (SLRPs) regulate assembly and
function of the ECM, particularly the collagen networks, and
include decorin, biglycan, asporin, fibromodulin, lumican, kera-
tocan, PRELP (proline arginine-rich end leucine-rich repeat
protein), osteoadherin (OSAD) and chondroadherin (CHAD)
[1]. Several SLRPs have roles in bridging between cells and
matrix by providing for interactions with cell surface receptors
such as syndecans (CHAD and PRELP) and integrins (CHAD and
OSAD) at the same time as binding to structural matrix proteins,
particularly fibril forming collagens exemplified in Camper et al.,
1997, Haglund et al., 2011, and Haglund et al., 2013. The
important roles of the SLRP molecules in matrix organization are
illustrated by the abnormalities in mice with inactivated SLRP
genes showing signs of dysregulation of collagen fibril formation
[2–5]. CHAD is a 38 kD protein, first isolated from bovine
cartilage [6]. It contains 11 leucine rich repeats (LRRs) and is
classified as a SLRP based on its primary structure [1]. CHAD is
highly expressed in cartilaginous tissues and is primarily located
close to the cells. Lower levels of expression are found in bone,
tendon [6–8] and eye [9]. In bovine bone, CHAD is implicated in
direct interaction with calcium phosphate mineral [10]. CHAD
mediates adhesion of isolated chondrocytes via two mechanisms:
one is binding via the a2b1 integrin [11] an interaction that can
mediate signalling between chondrocytes and their extracellular
matrix [12]; the other interaction is between the C-terminal
chondroadherin sequence and cell surface proteoglycans such as
syndecans that can act as receptors (Haglund et al., 2013). Bone
CHAD promotes attachment of osteoblastic cells (Mizuno et al.,
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1996) and binds with high affinity to collagen types I and II [13].
Also, CHAD interacts tightly with both the N- and C-terminal
globular domains of collagen type VI [14]. As CHAD can interact
with structural extracellular matrix (ECM) molecules as well as
with cells in the tissue, the protein may provide a mechanism for
regulating cell activities in relation to ECM structure, and thus,
play a role in both cartilage and bone homeostasis. CHAD has an
unusually restricted tissue distribution: In rat femoral heads,
CHAD is localized mainly in the territorial matrix at different
stages of articular cartilage development, and CHAD mRNA is
particularly prominent in the late proliferative cells in the
epiphyseal growth plate at young age [15]. We now report the
generation of a mouse with the CHAD gene inactivated (CHAD
2/2) and have performed detailed studies of its phenotype with
an emphasis on bone and cartilage homeostasis to reveal functions
of CHAD in vivo. We found that CHAD plays roles in the cartilage
development and maturation of the growth plate at young age and
in the molecular composition of articular cartilage in adults as well
as in bone homeostasis and function.
Results
2.1. Characterization of CHAD2/2 mice
CHAD null mice showed normal embryological development
and appeared healthy after birth. Macroscopically no phenotypic
abnormalities were visible and the mice appeared healthy up to
more than one year of age. Both female and male mice were fertile
and the CHAD2/2 breeding pairs did not differ in litter sizes
compared to WT.
2.2. Demonstration of gene inactivation and loss of
CHAD
In initial experiments a procedure for identification of
CHAD2/2 and WT mice was established by the use of PCR
of tail samples prepared by routine procedures (Svensson et al.,
1999) with primers selected to give different products when
CHAD was present or not. These products were distinguished by
Agarose gel electrophoresis (fig. 1a). WT mice demonstrated one
band of 650 bp while the null mice showed an expected band of
320 bp and the heterozygote showing both bands. The data
clearly demonstrate disruption of the CHAD gene in the null
animals. This was further substantiated by Western blotting
confirming the absence of CHAD in extracts from the null mice
as compared to wild-type cartilage, which showed robust
expression of CHAD. Liver tissue, which does not normally
express CHAD, was used as an additional negative control to
confirm that the antibody was not recognizing non-specific bands
(fig. 1b).
2.3. General morphology
Heart, lung including bronchial cartilage, kidney, liver and
spleen showed no histopathological changes by systematic
investigation at the light microscopic level of paraffin sections.
Since chondroadherin is expressed in the eye, a more detailed
study by semi thin epon sections was undertaken but showed no
differences (data not shown).
2.4. Tissue screening by DXA scanning
BMD, lean and fat content were measured in mice 6 weeks, and
3, 5 and 8 months of age. Results showed only very small
differences in 6 week-old males lacking CHAD compared to
controls. In this group the BMD/mg body weight was slightly lower
(CHAD2/2 = 1.7960.1 mm22, WT = 1.8860.4 mm22,
p = 0.03), so was the fat content measured in the whole mouse
(CHAD2/2 = 11.04%60.26, WT = 12.23%60.40, p = 0.03).
Apart from these differences, the DXA data did not reveal any
abnormalities in CHAD-null mice (data not shown).
2.5. Cartilage
2.5.1. The epiphyseal growth plate. Overall the CHAD2/2
mice presented a 35% increase in mean height of the femoral
epiphyseal growth plate at 3 weeks of age (p = 0.02, table 1), despite
normal length of the femur. When the relative height of each zone
was calculated, the resting zone was increased by 30% and the
proliferating zone by 45% in CHAD2/2 mice aged 3 weeks
(p = 0.04 and p = 0.007, respectively) (fig. 2). At 6 weeks of age the
proliferating zone was increased by 20% compared to WT mice
(p = 0.04).
2.5.2. Expression and localization of proteins in growth
plate cartilage. We analysed the expression and organization
of a number of proteins in the growth plate to discern differences
in the tissue organization upon CHAD inactivation. In both null
and wild type animals the distribution of mRNA showed the
expected pattern of expression: Cartilage oligomeric protein
(COMP) mRNA was primarily detected in the proliferative
chondrocytes of the epiphyseal growth plate, with no significant
difference between the groups. Osteopontin (OPN) and BSP were
both detected in hypertrophic chondrocytes, while there was no
detectable difference. Immunostaining for COMP was almost
exclusively localized to the epiphyseal growth plate, in addition to
some cartilaginous remnants in trabecular areas. The staining was
most intense in the territorial matrix along the columns of
proliferative chondrocytes, although pericellular staining was
observed to various degrees in all zones, and weaker staining
was observed in the interterritorial matrix (fig. S1). Histological
scoring of COMP staining did not demonstrate any differences
between CHAD2/2 and WT mice (data not shown).
2.5.3. Changes in the proteome of articular
cartilage. Initially there were 226 proteins identified by
MASCOT 2.1 from 5457 peptide matches above homology or
identity threshold. After filtering the data removing obvious false
positives (13 proteins) and protein hits with only one peptide hit, it
was possible to measure and calculate the relative ratios of 178
proteins detected in all extracts (table S1). The proteins identified
include the major components of the extracellular matrix in
cartilage such as collagens, aggrecan and members of the SLRPs
family. The comparisons were made without normalization
although the average ratios for all proteins were 0.8–0.9 suggesting
that the total protein content of the samples from the knockout
animals may be slightly lower than the corresponding wild type
samples. Overall most of the proteins were present at the same
level in the null compared with the WT mice. However, some
differences were noted (table 2). The null CHAD mouse vs. its wild
type counterpart showed increased levels of fibronectin (ratio 1.85
and 1.61 vs wild type). Both secreted parts of the gene product of
CILP 1 (CILP 1–1 and 1–2) were particularly elevated in female
null mice (ratio of 1.84 and 1.63, respectively). Markedly
decreased levels in the null mice were noted for alpha-1-antitrypsin
1 family members (ratio around 0.3) and apolipoprotein E.
Expectedly, CHAD in the null mice were at background noise
levels. In support no CHAD was detected in LC-MS analyses of
the individual samples of the CHAD null mouse. Corresponding
western blots showed no reactivity at all verifying that the sample
preparation is free from cross-contamination. Most other proteins
showed similar levels in null and wild type mice.
Chondroadherin Deficient Mice
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2.6. Bone
2.6.1. Micro-CT. Screening of mice aged 5 days, 3 week and
4 months showed that the length of the femora (i.e. the distance
between the distal growth plate and the gluteal tuberosity)
increased with time but was not significantly different between
CHAD2/2 and WT mice (table S2).
The 4 months old mice were analysed further. A number of
parameters expectedly showed significantly higher values for the
male wild type mice (table 3). Particularly noticeable differences
were the higher trabecular thickness and structure model index for
the null animals (p,0.05). There were also some noticeable
differences in the form of lower polar moment of inertia and
cortical diameter at midshaft only apparent for the male null
mouse (p,0.05), where values were more similar to those of the
females. The value for trabecular spacing in the female null mice
was lower than the wild type and more similar to those of the male,
although values did not reach significance.
2.6.2. Collagen fibres in bone. Qualitative electron micro-
scopic analysis of 6 weeks old CHAD2/2 mice showed no
abnormalities in the structure, tissue organization and thickness of
collagen fibrils in calvarial bone compared to WT mice (data not
shown).
2.6.3. Protein expression in bone. Tartrate resistant acid
phosphatase (TRAP) mRNA was primarily detected in metaph-
yseal osteoclasts; in addition, some resting and hypertrophic
chondrocytes in the growth plate also expressed TRAP. Cathepsin
K (CTK) mRNA was solely present in multinucleated cells in the
metaphyseal region. OPN mRNA was detected primarily in
osteoblasts lining the metaphyseal trabecular surfaces. As for
OPN, BSP mRNA was highly expressed in osteoblasts lining
trabeculae.
The relative number of BSP mRNA expressing cells was
significantly lower in the metaphysis of CHAD2/2 mice
compared with WT (p = 0.01) (fig. 3). Thus, the mean score in
the metaphysis for null mice was 0.4 (SD 0.9) as compared to WT
1.8 (0.4); n = 5 in both groups. No differences were found for
relative number of COMP, TRAP, CTK or OPN mRNA
expressing cells (data not shown).
2.6.4. Protein localization in bone. The most intense
accumulation of gold particles for both BSP (fig. S2) and OPN
was observed at electron dense extracellular areas representing
osteoid-bone interface/mineralization fronts, and to a lesser
extent, diffusely spread in mineralized bone. BSP exhibited a
characteristic pattern with labelling confined to discrete sites in
bone matrix corresponding to areas of early mineral deposition.
Semi-quantitative analysis revealed a trend towards increased
signal intensity in most compartments for both proteins in
CHAD2/2 mice (table 4). However, when each compartment
was compared between CHAD2/2 and WT mice, only BSP
labeling in osteoid was found to be significantly increased
(table 4).
2.6.5. Mechanical properties of bone. All mechanical
properties increase significantly from 6 weeks to 4 months of age
(fig. 4). Femoral neck failure load (fig. 4a) was significantly lower
in the 4 month old CHAD2/2 mice compared to the same age
and gender wild type (p,0.01). The difference between
CHAD2/2 and wild type female at 4 months was small and
not significant although again the wild type may show somewhat
higher bone strength. Males showed higher strength than
Figure 1. Analyses of message and proteins in CHAD2/2 and WT mice. A: PCR and agarose gel electrophoresis of mouse tail samples. There
is a faint, barely visible, reactivity at the position of the wild type allele (320 bp), but this is not observed in the CHAD2/2 mice. It probably
represents some weak reactivity of the wild type allele by the primers for the deleted allele B: Protein stained gel and Western blot of cartilages and
liver as a control for non-specific reactions. Different cartilages were extracted with 4 M guanidine hydrochloride, proteins precipitated with ethanol
and electrophoresed on 4–16% SDS-PAGE. Left picture represents a Coomassie stained gel and the right picture represents Western blots with the
anti-CHAD antibody. The lanes represent extracts of 1. Trachea (2/2); 2. Nasal cartilage (2/2); 3. Knee cartilage (2/2); 4. Trachea (+/+); 5. Nasal
cartilage (+/+); 6. Knee cartilage (+/+); 7. Liver (+/+); 8. Recombinant CHAD; 2/2 represents CHAD2/2 and +/+ wild type mice.
doi:10.1371/journal.pone.0063080.g001
Chondroadherin Deficient Mice
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females. In contrast at 8 month there were no observable
differences between the mice whether wild type-mutant or
female-male were compared. Interestingly the strength of the
4 months wild type male mice appeared higher than that of
8 months animals. The tibial strength (fig. 4b) showed similar
trends to the femoral neck strength. The null mice showed
significantly lower strength than the wild type at 4 months both
for males and females (p,0.001). At 8 months differences could
not be discerned.
Discussion
CHAD deficient mice did not show gross anatomical defects,
grew to normal size, were fertile, and had a normal life span up to
2 years of age, which is in line with other studies with SLRPs-null
mice [2–5]. However, the CHAD deficient mice presented a
distinct skeletal phenotype, demonstrating a role for CHAD in
cartilage and bone turnover. With the exception of increased levels
of CILP-1 and fibronectin in the female CHAD deficient mouse,
alterations in the identifiable extracellular matrix proteins proper
in articular cartilage were small. The altered levels of both CILP
proteins in particularly the female mice, albeit still only by some
50%, are interesting but at this time the functional implications are
not known. It can be noted that CILP is a protein up regulated in
osteoarthritis (Bernardo et al., 2011), and there is a polymorphism
that correlates to a higher incidence of lumbar disc disease (Seko et
al., 2005). The mice at the ages studied showed no signs of either
joint or spine disease. An unexpected finding was the consistently
low levels of several variants of alpha-1-antitrypsin. This might
affect the susceptibility against proteolytic activity and thereby also
overall tissue stability. Interestingly, it is rather obvious that none
of the other SLRP proteins are differently expressed following the
removal of CHAD.
3.1. Disturbances in the epiphyseal growth plate but
normal collagen organization
The CHAD 2/2 mice presented a widened epiphyseal growth
plate. This was most pronounced in the proliferative zone at 3 and
6 weeks of age which fits well with data showing that CHAD is
synthesized mainly by late proliferative chondrocytes [7]. The
balance between proliferation and differentiation of chondrocytes
is an important regulatory step controlled by multiple signalling
molecules, including the Indian hedgehog (Ihh)/parathyroid
hormone related peptide (PTHrP) feedback loop [16]. Interest-
ingly, Ihh, which is upstream in the signalling pathway of PTHrP,
shows a similar distribution of expression to that of CHAD [17].
Ihh controls the transition from proliferating to hypertrophic
chondrocytes [16], thereby regulating the height of the prolifer-
ative zone. Thus, based on the very distinct localization around a
portion of the proliferative chondrocytes, the apparent absence of
cell spreading and growth of chondrocytes on CHAD coated
surfaces [18], as well as the observed widening of the proliferative
zone in null mice, it could be speculated that CHAD may
influence the Ihh/PTHrP feedback loop and/or participate in the
control of chondrocyte development by promoting their differen-
tiation into the hypertrophic stage. However, the lack of detectable
differences in bone length between null and WT mice suggest that
CHAD influences chondrocyte maturation only to a modest
degree or that other processes compensate by modulating
subsequent events. It has been documented that CHAD interacts
with collagen and the protein is abundant in the territorial matrix,
suggesting a role in early assembly and function of fibrillar
collagen [13]. However, CHAD-null mice showed normal
collagen organization and fibril diameter in the bone, indicating
either that other molecules than CHAD play more prominent
roles in the process or that CHAD differs from other SLRPs not
only with respect to localization, but also regarding its function vis-
a`-vis collagen [4].
Figure 2. Micrographs of the epiphyseal plate in CHAD 2/2
and WT mice. Light micrographs of CHAD2/2 (2a) and WT (2b) mice
at 3 weeks of age. A small but significant increase in the height of the
growth plate mostly confined to the proliferative zone was confirmed
by histomorphometry (table 3). Epon-embedded tissue, toluidine blue
staining (x 20).
doi:10.1371/journal.pone.0063080.g002
Table 1. Histomorphometric analyses of the epiphyseal
growth plate in 3 and 6 weeks old CHAD2/2 mice and age-
matched WT mice.
3 weeks old 6 weeks old
Zone CHAD2/2 WT CHAD2/2 WT
Epiphyseal height – 288654 * 214614 269631 238644
Height of zone Resting 3968 * 3064 3263 3769
Proliferating 155627 ** 10766 151616 * 126623
Hypertrophic 94623 7768 85615 74614
Osteoid surface Metaphysis – – 2166 1765
Values are mean 6 SD. For epiphyseal values (mm), n = 6/4 and n = 6/8 for
CHAD2/2 and WT mice after 3 and 6 weeks, respectively. For osteoid values (%
of trabecular surface), n = 7/6. *p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0063080.t001
Chondroadherin Deficient Mice
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3.2. Altered mechanical properties, cortical/trabecular
bone parameters and loss of sex-specific differences
Significant differences in trabecular/cortical parameters were
apparent at the age of 4 months, where the null mice presented
significantly higher BMD, lower cortical thickness, increased
trabecular thickness, and increased structure model index (SMI) by
micro-CT. SMI is a measure of the ratio of ‘‘plate-like’’ to ‘‘rod-
like’’ trabecula within a trabecular bone specimen and higher
density cancellous bone generally shows more ‘‘plate-like’’
trabecula. Interestingly, osteoporotic trabecular bone transits from
plate-like to rod-like, increasing the SMI [19]. Thus, increased
SMI of the trabecular bone in the null mice is consistent with
impaired mechanical properties. In line with the micro-CT data
indicating disturbed formation and/or remodelling of bone, the
mechanical testing showed reduced mechanical strength of both
femoral neck cancellous bone and tibial cortical bone at 4 months.
This was most pronounced for the male mice, possibly reflecting
different rates of bone turnover between male and female. The
older 8 months mice showed no such discernable difference,
perhaps indicating a lower bone metabolism at this age.
Noteworthy, this group of mice was based on the C57BL/6 strain
which has been shown to have larger cortical cross-section areas
but to be less responsive to increased mechanical loading than
other used strains, e.g. the C3H/He and DBA/2 (Robling et al.,
2002). Our data show that CHAD influences both cortical and
trabecular bone formation and/or remodelling. The male null
mice showed an appearance of the studied variables more similar
to the parameters observed for the wild type female mice. Our
data suggest that CHAD is important in the sex-specific
development of the skeleton. Such loss of sex-specific differences
has previously also been reported in OPN deficient mice [20].
3.3. Decreased number of cells expressing BSP mRNA
Non collagenous proteins of the SIBLING (small integrin-
binding ligand, N-linked glycoprotein) family (Fisher et al., 2001),
which includes OPN and BSP, are believed to play key biological
roles in the development, turnover and mineralization of bone
(reviewed in [21] and [22]). Both BSP and OPN are secreted by
osteoblasts and have been shown to modulate osteoblast differen-
tiation and mineralization in vitro. BSP for the most part promotes
Table 2. Changes in the proteome of cartilage from mice with the CHAD gene inactivated.
Acc. No. Protein name Fem KO vs Wt Male KO vs Wt
P11276 Fibronectin 1,85 1,61
Q66K08 Cartilage intermediate layer protein 1 1,75 1,18
P31725 Protein S100-A9 1,02 0,21
Q9Z1F6 Chondromodulin-1 0,97 0,49
P29699 Alpha-2-HS-glycoprotein 0,82 0,46
P62259 14-3-3 protein epsilon 0,68 0,33
P63101 14-3-3 protein zeta/delta 0,66 0,32
P22599 Alpha-1-antitrypsin 1-2 0,39 0,27
Q00898 Alpha-1-antitrypsin 1-5 0,38 0,28
Q00897 Alpha-1-antitrypsin 1-4 0,38 0,27
Q00896 Alpha-1-antitrypsin 1-3 0,38 0,25
P07758 Alpha-1-antitrypsin 1-1 0,37 0,25
P08226 Apolipoprotein E 0,36 0,35
Acc. No. Protein domains Fem KO vs Wt Male KO vs Wt
P28481 Collagen alpha-1(II) chain 1,23 1,40
P28481 Collagen C-propeptide 0,90 0,81
P28481 Collagen N-propeptide 1,00 1,37
Q66K08 Cartilage intermediate layer protein 1-2 1,84 1,27
Q66K08 Cartilage intermediate layer protein 1-1 1,63 1,06
D3Z7H8 Cartilage intermediate layer protein 2-2 1,46 1,08
SLRP proteins
Q99MQ4 Asporin 0,90 1,11
P28653 Biglycan 1,16 1,11
P28654 Decorin 1,00 1,05
P70186 Epiphycan 0,84 0,90
P50608 Fibromodulin 1,01 1,05
P51885 Lumican 0,98 0,92
Q62000 Mimecan 0,80 0,89
O35103 Osteomodulin 0,77 1,02
Q9JK53 Prolargin 1,10 1,17
doi:10.1371/journal.pone.0063080.t002
Chondroadherin Deficient Mice
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Table 3. Micro-CT cortical/trabecular bone parameters in 4 month old mice.
Parameter Male KO Male WT Female KO Female WT Average KO Average WT
Bone length (mm) 7.0460.36 6.8260.52 6.7560.28 7.2760.35 6.89 60.34 7.1060.45
Ct.Th (mm) 0.1860.01 0.1760.02c 0.1860.01b 0.1960.01 0.1860.01 0.1860.02
vBMD (g/cm23) 1.5760.08 1.5160.04c 1.5560.08 1.5960.06 1.5660.08 1.5660.07
Ct.BV (mm3) 99.6160.58 99.6660.17 c 99.6260.44 99.8260.07 99.6160.50 99.7660.14
Ct.P (%) 0.3960.58 0.3460.17 c 0.3860.44 0.1860.07 0.3960.50 0.2460.14
Tb.BV (%) 7.4361.37 7.4361.44 d 5.1362.27 4.3560.69 6.2862.13 5.5161.85
Tb.P (%) 92.5761.37 92.5761.44 d 94.8762.28 95.6560.69 93.7262.13 94.4961.85
Tb.Th (mm) 0.04660.003 0.04260.005 0.04360.004 0.04160.002 0.04560.003a 0.04160.003
Tb.Sp (mm) 0.2760.01 0.2760.01c 0.2960.02 0.3360.03 0.2860.02 0.3160.04
DA 2.1460.20 2.1660.13 2.2460.35 2.5660.54 2.1960.27 2.4160.46
SMI 2.4360.11b 2.2360.01c 2.5360.36 2.4260.07 2.4860.25a 2.3460.11
MMI (mm4) 0.3360.02a 0.7260.15d 0.3460.06 0.3560.04 0.3360.04 0.4960.21
D (mm) 0.9760.01a 1.1560.06d 0.9960.04 0.9960.02 0.9860.04 1.0560.09
Bone length, cortical/trabecular thickness (Ct.Th/Tb.Th), volumetric BMD (vBMD), cortical/trabecular porosity (Ct.P/Tb.P), trabecular separation (Tb.Sp), degree of
anisotropy (DA), structure model index (SMI), polar moment of inertia (MMI) at midshaft, and equivalent circle diameter (D) at midshaft of femur in CHAD2/2 (KO) and
WT mice. a: p#0.05 KO vs. WT, b: p#0.05 KO male/female vs. WT male/female, c: p#0.05/d: p#0.01 males vs. females in same group. Taken together the data clearly
demonstrate an altered bone homeostasis in the mice with the chondroadherin gene inactivated.
doi:10.1371/journal.pone.0063080.t003
Figure 3. BSP mRNA expressing cells in the distal femur of CHAD2/2 and WT mice at 6 weeks of age. In situ hybridization showed
intense signal in multiple osteoblastic cells (arrows) in the metaphysis (M) of WT mice (3b), while CHAD2/2 mice (3a) showed very sparse signal in
cells in the corresponding area (p = 0.01). Also chondrocytes in the epiphyseal growth plate (EGF) showed signal, although no quantitative difference
in number of cells were detected between the groups at this site (x 20). Negative control with sense probe was without signal (3c).
doi:10.1371/journal.pone.0063080.g003
Chondroadherin Deficient Mice
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the process [23–25]. Interestingly, a considerable decrease in the
number of BSP mRNA expressing cells was noted in the CHAD
null mice. This decrease together with the slightly increased
osteoid surface observed in the femoral metaphysis of these mice
may imply impaired mineralization. On the background of altered
cortical/trabecular parameters and decreased number of BSP
mRNA positive cells in the distal femur metaphysis of CHAD-null
mice, we extended the study of BSP and OPN and investigated
their protein distribution in bone at the ultrastructural level.
Despite a tendency towards increased signal intensity in osteoid,
over osteoid-bone interfaces/mineralization fronts as well as in
mineralized bone for both proteins in CHAD-null mice, there was
no overall significant difference in the protein distribution pattern.
However, this observation is not necessarily contrary to the in
situ hybridization data, as protein distribution in the tissue depends
not only on synthesis but also on secretion and degradation in the
ECM. Thus, although there are fewer cells expressing BSP mRNA
in CHAD-null mice, the protein synthesis of those expressing the
gene appears normal, and the number of cells expressing OPN is
normal. Thus, taken together, the CHAD null mouse appears to
have an altered and lower bone turnover.
Conclusions
The present study has provided the first evidence that the
absence of CHAD leads to a distinct skeletal phenotype
characterized by widening of the epiphyseal growth plate with
possible impaired of hypertrophic differentiation of chondrocytes,
reduced number of BSP expressing cells, disturbed molecular
composition of articular cartilage and structural and functional
alterations in trabecular and cortical bone tissue with alterations in
bone turnover.
Materials and Methods
This study was carried out in strict accordance with the
institutional guidelines for animal research at Lund University,
Sweden. The protocols were approved the Committee on the
Ethics of Animals at Lund University, Sweden (Permit Numbers:
M31-09 and M177-11).
5.1. Generation of CHAD2/2 mice
A mouse genomic cosmid library was screened using a 887-bp
CHAD rat cDNA fragment as described [26]. A 31 kbp genomic
DNA fragment was isolated and partly sequenced. Out of this a
3000 bp fragment including the ATG of the CHAD gene was
Table 4. Ultrastructural distribution of OPN and BSP in bone of CHAD2/2 and WT mice.
OPN BSP
Compartment CHAD2/2 (n = 6) WT (n = 6) CHAD2/2 (n = 6) WT (n = 6)
OB nucleus 1.5360.46 1.3260.41 0.9460.19 1.0860.19
OB cytoplasm 1.6960.38 1.7060.36 0.8260.15 0.7260.18
Osteoid 4.5462.50 3.7062.06 1.2060.21* 0.9360.14
Mineralization front 150.18651.42 124.21656.63 16.5165.60 15.3566.45
Mineralized bone 15.96612.40 9.3066.77 3.8360.88 2.9860.68
Capillary lumen 0.8060.22 0.5760.20 0.4660.07 0.5060.15
Semi quantitative analysis of the ultrastructural protein distribution in CHAD2/2 and WT mice. Values are mean 6 SD gold particles/um2 per animal. OB = osteoblast.
* p,0.05 when compartments are directly compared.
doi:10.1371/journal.pone.0063080.t004
Figure 4. Mechanical properties of bone. 4a: Femoral neck failure load (Newtons) for 6 weeks, 4 months and 8 months old wild type (wt) and
CHAD2/2male and female mice. The difference between CHAD2/2 and wt in 4 months old male mice is significant (p,0.01). 4b: Tibial shaft failure
load (Newtons) for 6 weeks, 4 months and 8 months old wild type (wt) and CHAD2/2 male and female mice. The difference between CHAD2/2
and wt in 4 months old mice is significant for both genders (p,0.001).
doi:10.1371/journal.pone.0063080.g004
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inserted to the pWH9 vector (kindly provided by Dr. R. Fa¨ssler)
that carries a phosphoglycerate kinase-neomycin resistance cas-
sette (pGKNeo). The 3000 bp fragment was inserted 59 of the
neocassette. In the 39end of the cassette a 7000 bp CHAD
fragment was inserted.
5.1.1. Generation of recombinant ES cell lines and
chimeric mice. Approximately 206106 semi-confluent R1
embryonic stem (ES) cells (kindly provided by professor Reinhard
Fa¨ssler) (Nagy et al., 1993) were electroporated with 80 mg
linearized targeting vector. The ES cells were cultured on feeder
cells in DMEM supplemented with fetal calf serum and leukemia
inhibitor factor (for reference see[27]). After 24 hours of culture,
selection for positive clones was initiated by the addition of
500 mg/ml G418. Positive clones were picked, expanded and
DNA was purified and subsequently analyzed by Southern Blot
analysis for confirmation of the correct targeting events. Targeted
ES-cells were injected into mouse blastocysts according to
standard procedures. Chimeric males were mated with C57BL/
6 females and males with germ line transmission were further bred
with 129/sv females to establish a strain of CHAD-null mice.
Before analyses, the mice were backcrossed for 10 generations into
the C57BL/6 background.
5.1.2. Genotyping of CHAD2/2 mice. Genomic DNA
from tail tendon was purified, digested with EcoR1 and separated
on an agarose gel using standard procedures. A 1000 bp XbaI-
HindIII fragment was used as a probe in the hybridization. This
probe detects a 16 kbp fragment in the wild type (WT) mouse and
a 13 kbp fragment in the targeted mouse.
PCR was used to detect homologous recombination of the
mouse CHAD gene. A 59primer 59CAG TCT GGT CTT TCT
TGC CA was used together with a 39primer 59ATG TCG TTG
TGG GAC AGG TA. This detects a 320 bp fragment in the WT
mouse. An additional primer corresponding to the sequence
59CGC CTT CTT GAC GAG TTC TT in the neo-cassette was
used to detect a fragment of 650 bp corresponding to homologous
recombination in the knock-out.
5.2. Skeletal X-ray analysis
Bone mineral density (BMD), fat and lean content were
examined with dual-energy X-ray absorption (DXA) using the
Lunar PIXImus Densitometer (GE Medical Systems). Measure-
ments were performed on null and WT mice at the age of 6 weeks,
and 3, 5, and 8 months of age (males and females separately). At
each time-point at least 6 CHAD2/2 and 6 WT animals were
measured. The measurements were performed on anaesthetized
living animals.
5.3. Micro computed tomography
Micro computed tomography (micro-CT) was performed as two
experiments: first, femora of mice sacrificed at 5 days, 3 weeks and
4 months of age, respectively, were included as a general
screening. In the second experiment, in depth analyses were
performed in both sexes of 4 months old mice (4 male and 4
female CHAD2/2, and 5 male and 3 female WT mice). All
specimens were scanned by the use of high-resolution micro-CT
(SkyScan 1172; SkyScan, Kontich, Belgium). Dissected whole
femora were affixed to the scanning stage and projection images
were obtained at a resolution of 8.03 mm and reconstructed by use
of manufacturer-provided software (NRecon, SkyScan). After
calibration of the standard unit of X-ray CT density (Hounsfield
unit, HU), the conversion from HU to volumetric bone mineral
density (vBMD) was done. Reconstructed images were analyzed by
use of manufacturer-supplied software. Three sections as shown in
fig. S3 consisting of 63 slices or 0.5006 mm (5 days old mice) or
126 slices or 1.012 mm (3 weeks and 4 months old mice) were
analyzed per bone for the following parameters: cortical thickness,
cortical porosity, cortical bone volume, trabecular thickness,
trabecular separation, trabecular bone volume, trabecular poros-
ity, as well as degree of anisotropy (DA) (from mean intercept
length analysis as an index of degree of preferred orientation of the
structure [28]) and structure model index (SMI) (the amount of
plates and rod composing the structure [19]). A threshold of 45,
66, and 86 to 255 was applied for 5 days, 3 weeks and 4 months
old mice, respectively (fig. S4). Cortical vBMD was obtained after
applying a threshold of 1–255 to sections of cortical bone.
5.4. Macroscopic and light microscopic analyses
At sacrifice the mice were subjected to macroscopic work up
aiming at detection of malformation. Moreover, samples from
heart muscle, kidney, spleen, liver and lung were fixed in formalin,
paraffin-embedded, sectioned and stained with haematoxylin &
eosin (H&E) according to a routine protocol. Intact eyes were fixed
in 2% glutar aldehyde and embedded in an epoxy resin (Epon 812,
Agar Scientific ltd., Stansted, Essex, UK) and equatorial semi thin
sections were stained with toluidine blue according to a routine
protocol. Three to five coded sections per organ and animal were
subjected to conventional light microscopy by an experienced
surgical pathologist and evaluated for structural tissue changes. Six
animals (CHAD2/2 and WT) were investigated at each age, i.e.
3 and 6 weeks as well as 3 and 8 months.
5.4.1. Bone histomorphometry. Femora from 3 and
6 weeks old animals were fixed in glutar aldehyde, decalcified in
7% EDTA for 15 days and embedded in an epoxy resin as above.
Semi thin longitudinal sections of distal femoral metaphyses were
cut and stained with toluidine blue, and histomorphometric
analysis was performed on digital images (resolution 257661932
pixels) using image analysis software (AnalySIS pro, Digital Soft
Imaging System, Mu¨nster, Germany). Mean height of the
epiphyseal growth plate was calculated for each section using the
mean of 10 randomly placed lines for measurement. The relative
zonal distribution of the resting, proliferative and hypertrophic
zone was estimated by point counting.
Femora for measurement of osteoid were fixed in 4% buffered
formalin, embedded in a methyl methacrylate resin (K-plast,
DiaTec Systems, Germany) without prior decalcification, sec-
tioned and stained with Masson-Goldner’s trichrome. Relative
osteoid surface (% of trabecular surface) was estimated by point
counting. For each animal, a minimum of 3 non-overlapping
visual fields of vision were analyzed.
5.4.2. In situ hybridization. Five to six 6 weeks old animals
from each group were subjected to in situ hybridization with
riboprobes for OPN, CTK, BSP, TRAP and COMP. Gene
sequences for TRAP, CTK, COMP, OPN and BSP were
amplified by conventional PCR using cDNA from mouse
osteoblasts (a generous gift from dr. Rune Jemtland, Oslo
University Hospital, Norway) or IMAGE clones using the
oligonucleotide primers listed in table S3. All sequences were
subsequently cloned with a Dual Promoter TA Cloning Kit
(Invitrogen) and sequenced. Digoxigenin (DIG)- conjugated
complementary RNA cRNA) probes were synthesized with a
DIG-labelling kit (Roche Diagnostics AS, Oslo, Norway) using T7
or Sp6 RNA polymerase to yield probes in the sense or antisense
orientation. Hybridization of longitudinal sections of formalin-
fixed femora embedded in paraffin was performed by modification
of a previously described protocol [29]. Briefly, dewaxed and
proteinase K-digested sections of paraffin-embedded samples were
post-fixed in paraform aldehyde. Following prehybridization in
formamide/26SSC, the sections were hybridized with 5 ng probe
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in 50% formamide/26 SSC/7.5% dextran sulphate. High
stringency washing was performed, and unbound probe was
removed by RNase-treatment. Hybridized probe was detected
using an alkaline phosphatase (AP)-conjugated sheep anti-DIG
antibody followed by the AP-substrate nitrobluetetrazolium
chloride (NTB)/5-bromo-4- chloro-3-indolyl-phosphate (BCIP)
(Roche Diagnostics GmbH, Mannheim, Germany). Coded
sections of the epiphyseal growth plate and the metaphysis of
the distal femur were micrographed and analyzed focusing on the
resting zone, the proliferative zone, the hypertrophic zone, and the
metaphysis. The following scoring system was used to semi-
quantify mRNA positive cells; 0 = no positive cells, 1 = low
concentration of positive cells, 2 = high concentration positive
cells.
5.4.3. Immunohistochemistry. Ten 6 week old animals
from each group were included in the analysis. Immunohisto-
chemistry of COMP was performed using the peroxide technique
with diaminobenzidine (DAB) as the chromogen according to a
routine protocol (Hect et al., 2004). Longitudinal sections of
formalin-fixed femoral bone sections embedded in paraffin were
used. Following permeabilisation by digestion with chondroitinase
ABC (Seikagaku Corporation, Tokyo, Japan) in tris/acetate buffer,
the sections were incubated with rabbit polyclonal antiserum
raised to rat COMP [30]. Bound antibodies were visualized using
the Dako EnVision+ System (EnVision+ System, HRP K4010,
DAKO, USA). The sections were counterstained with haematox-
ylin and subsequently with a mixture of eosin and phloxine B.
COMP-staining was confined to the articular cartilage and the
epiphyseal growth plate, and the latter was subjected to semi –
quantitative analysis. Thus, the growth plate was divided into the
following zones; I (resting and proliferative zones) and II
(hypertrophic zone). In zone I, scores (0 = no staining, 1 = weak
staining and 2 = intense staining) for territorial matrix and
interterritorial matrix were analyzed, while in zone II, pericellular,
interterritorial and intracellular staining were graded.
5.5. Transmission electron microscopy
Tibias from 6 weeks old mice were immediately dissected free
and fixed by immersion in a solution of 2% paraform aldehyde
and 0.5% glutar aldehyde (GA). Subsequently, the tissue was
embedded at low temperature in a freeze substitution device
according to our established protocol [31].
5.5.1. Qualitative ultrastructural collagen
analysis. Coded ultrathin sections from GA-fixed, epon-em-
bedded samples of calvarial bone of 6 weeks old CHAD 2/2 and
WT mice were subjected to electron microscopy of collagen fibrils.
The fibrils were evaluated semi-quantitatively for thickness and
spatial orientation. Sections from two blocks of each of 6 animals
(3 CHAD2/2 and 3 WT) were investigated and categorized as
normal or pathological.
5.5.2. Immunogold labelling and semi-quantitative
analysis. Immunogold labelling with antibodies against BSP
and OPN was performed as previously described [32]. Micro-
graphs were obtained by systematic random sampling of cells/
surrounding matrix and analyzed using the semiautomatic
interactive image analyzer software AnalySISH pro (Soft Imaging
System, Mu¨nster, Germany). In consensus with previous reports of
the ultrastructural distribution of BSP [33,34] and OPN [31,35],
regions of interests were confined to 1) osteoblast nucleus, 2)
osteoblast cytoplasm, 3) osteoid, 4) osteoid-bone interface/
mineralization fronts and 5) mineralized bone. Six animals from
each group were included in the analysis, and 2 tissue blocks were
sampled per animal. The results for OPN and BSP are based on
the analysis of 60 osteoblasts and their surrounding microenvi-
ronment in each group.
5.6. Protein contents of femoral head cartilage by
proteomics
5.6.1. Dissection, pulverization and protein extraction of
cartilage. Samples were obtained from G3 mice 4 months old.
Full thickness femoral head cartilage was dissected from 8 female
CHAD 2/2, 7 female wild type, 7 male CHAD 2/2, and 7
male wild type. The tissue from each group was pooled separately
and homogeneous powder was made in liquid nitrogen. The
samples were extracted with guanidine hydrochloride with added
proteinase inhibitors (Larsson et al., 1991) and extracts were
collected after centrifugation (IEC Micromax) at 13200 rpm for
30 min.
5.6.2. Preparation of proteins in extracts for quantitative
proteomics and analyses. Procedures for quantitative proteo-
mics were the same as those described for the analyses of a set of
human cartilage tissues. Essentially, proteins in extracts were
reduced and alkylated, followed by trypsin digestion (Onnerfjord
et al., 2012). An isobaric 4-plex ITRAQTM was then used to
enable simultaneous analysis of a mix of all the four samples.
Trypsin digests of the four pools of cartilage were separately
labelled using standard protocols according to the manufacturer.
The trypsin digested labelled extracts were combined and
chromatographed on a SCX cation exchange column. The 29
fractions collected were separately applied to and analyzed using a
reversed phase C18 nano-LC column online with a QTOF mass
spectrometer as described (Onnerfjord et al., 2012).
5.6.3. Database searching. The mass spectrometric raw
data was processed using Protein Lynx 2.1 with internal
calibration. The processed files were searched with taxonomy
mus musculus using MASCOT 2.1. The ratios of individual
peptides between female CHAD 2/2 vs. wild type, male CHAD
2/2 vs. wild type, female CHAD2/2 vs. male CHAD 2/2,
and female wild type vs. male wild type mice were calculated by
MASCOT.
5.6.4. Data analysis. iTRAQ quantification parameters:
significant threshold p,0.05; weighted average ratios; minimum
number of peptides of 2, minimum precursor charges of 2; at least
homology of 0.05. The searched list was manually inspected for
errors and a limited number of obviously incorrectly identified
proteins were removed e.g. non-collagenous proteins identified
with hydroxylation on proline residues.
5.7. Analysis of tissue protein pattern by SDS-
polyacrylamide gel electrophoresis and presence of
CHAD by Western blot
Cartilage from the femoral head, trachea and nose were
dissected clean, cut into small pieces and extracted with guanidine-
HCl (GuHCl) containing a proteinase inhibitor cocktail according
to standard procedures [6]. For control of antibody specificity in
the Western blot a liver sample was treated in the same way.
Samples of extracts corresponding to 1 mg of wet weight tissue
were precipitated with ethanol and electrophoresed on SDS-
polyacrylamide 4–16% gradient gels followed by Western blotting
as described [6,36]. The antibody used to stain the blot was raised
in rabbits against bovine CHAD [6].
5.8. Testing of mechanical properties of bone by
fracturing
Mice were sacrificed at 6 weeks, 4 or 8 months of age and
frozen at 220uC. At the time of testing the mice were thawed, the
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femora and tibiae were dissected out and kept wet being wrapped
in saline soaked tissue at 4uC overnight prior to testing. Two
different mechanical tests were performed aimed at measuring
femoral neck for the properties of cancellous bone and tibia for
cortical bone. The strength of the cancellous bone of the femoral
neck was measured using a miniaturised version of the mechanical
test previously developed to test total hip replacements (Thompson
et al., 2004). The bone was gripped in a cylindrical holder, which
was then held at 9˚ to the vertical, orientated so that the bone was
vertical in the sagittal plane and in valgus in the frontal plane, thus
similar to the position of the femur in vivo. Using an InstronH
8511.20 biaxial load frame with an MTSH TestStar II controller,
displacement was applied to the femoral head, using a flat ended
indenter, at 0.1 mm s21 until fracture occurred. Care was taken to
ensure that the load was applied to the top of the femoral head,
such that the loading indenter was not touching the greater
trochanter. Fracture lead to a drop in the applied load. After
removal from the mechanical test machine the specimen was
checked visually to ensure that the fracture had occurred through
the femoral neck, the data was rejected ff the fracture had
occurred outside the femoral neck. The load at fracture of the
femoral neck was registered. Tibias were used for cortical bone
testing after dissection and removal of the fibula just proximal to its
insertion into the tibia. The tibia was then placed on two supports
of an 8 mm span three point loading rig. The bone was positioned
so the supports were under the curve in the proximal tibia and at
the distal tibia so that when the load was applied at the mid point
between the supports it was through the point of insertion of the
fibula. Loading was applied at 0.1 mm s21. In preliminary tests it
was found that this position was stable, reproducible and that the
tibia did not rotate during the test. The stiffness was measured
over the linear portion of the loading curve and the load at failure
was recorded.
5.9. Statistics
Morphological and micro-CT results are given as mean 6
standard deviation (SD) and differences between CHAD2/2 and
WT animals were tested using a two-tailed independent Student’s
t-test. A multivariate analysis of variance (MANOVA) was used to
compare immunogold data. For the latter, interest was focused on
whether the overall distribution pattern for each of the two
proteins differed between the groups. Thus, for a protein, only
differences in overall comparison between the groups using
MANOVA, and not difference in tests between subjects, were
considered. A p-value of ,0.05 was considered significant for all
analyses.
Supporting Information
Figure S1 Immunostaining for COMP in the epiphyseal
growth plate at 6 weeks of age. The epiphyseal growth plate
(EGF) showed intense staining for COMP in both interterritorial
and territorial matrix, although the staining did not differ by
histologic scoring between CHAD2/2 (3a) and wild type mice
(3b). Non-immune control was negative (3c) (610). Counterstained
with H&E and phloxine B.
(TIF)
Figure S2 Ultrastructural protein distribution of BSP in
bone at 6 weeks of age. Sections incubated with anti-BSP
showed distinct accumulation of gold particles over cement lines/
mineralization fronts (arrows) in areas of mineralized bone but
quantitative comparison revealed no differences in distribution
pattern between the CHAD2/2 (4a), wild type mice (4b) and
non-immune control (4c) (TEM,649,000).
(TIF)
Figure S3 Positions of the 3 sections analyzed in the
femur of 4 months old mice by micro-CT.
(TIF)
Figure S4 Threshold levels in comparison to the
original grey scale scan for the 3 different age groups
in the screening micro-CT experiment.
(TIF)
Table S1 The proteins identified by MASCOT 2.1 from
5457 peptide matches above homology or identity
threshold, and ratios in CHAD2/2 (KO) versus wild
type (WT) mice. Proteins identified by only one peptide were
excluded. Proteins that changed $50% are underlined.
(DOCX)
Table S2 Micro-CT cortical/trabecular bone parame-
ters at different ages. Bone length (femur), cortical/trabecular
thickness (Ct.Th/Tb.Th), cortical volumetric BMD (Ct. vBMD),
cortical/trabecular bone volume (Ct.BV/Tb.BV) cortical/trabec-
ular porosity (Ct.P/Tb.P), trabecular separation (Tb.Sp), degree of
anisotropy (DA) and structure model index (SMI) in proximal (P),
middle (M) or distal (D) femur. * p,0.05, **p,0.01 between
CHAD2/2 and wild type (WT) mice in the age-group.
(DOCX)
Table S3 Oligonucleotide primer sequence for DIG-
labeled cRNA probes.
(DOCX)
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